by rss feed | Oct 24, 2026 | News Feeds
Adding abiraterone to standard treatment provides a lasting survival benefit for men whose prostate cancer has already spread at diagnosis, reinforcing the value of early treatment intensification. Read Original...
by rss feed | Oct 24, 2026 | News Feeds
An immunotherapy-based regimen combining durvalumab and the PARP inhibitor, olaparib, demonstrated encouraging long-term survival outcomes for patients with advanced or recurrent endometrial cancer, according to new trial results presented by researchers from The...
by rss feed | Oct 24, 2026 | News Feeds
Public health researchers have long examined how societal forces can shape health outcomes. Decades after redlining was outlawed, for example, researchers continue to document its lasting effects on life expectancy, chronic disease and access to healthcare resources...
by rss feed | Oct 24, 2026 | News Feeds
SAFE Structure Designs, a Las Vegas-based defense engineering and manufacturing company led by President and CEO Johnny Buscema, is supporting 50 Legs as a donor and raising awareness of its work helping children and adults with limb loss access quality prosthetic...
by rss feed | Oct 24, 2026 | News Feeds
The American Society of Nephrology, has selected the following late breaking clinical trials to be presented in-person at Kidney Week 2026 October 22–25. Read Original...